Ataraxis AI
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $24M
Investors
- 7
About Ataraxis AI
Founded in 2023 and based in New York, US, Ataraxis AI, Inc. focuses on developing AI-driven diagnostic tools, including its flagship product, Ataraxis Breast, which evaluates cancer aggressiveness and treatment efficacy. Jan Witowski (CEO) and Krzysztof Geras are the co-founders of the company. In March 2025, Ataraxis AI, Inc.ai specializes in advanced artificial intelligence solutions for cancer prognosis and treatment selection, particularly through its flagship product, Ataraxis Breast. This AI-native prognostic and predictive test integrates multi-modal data to assess the aggressiveness of breast cancer, predict risks of recurrence or death, and evaluate the efficacy of various treatment options for patients. Developed with clinical data from over 8,161 patients across 15 institutions, Ataraxis Breast identifies low- and high-risk patients. The technology leverages proprietary AI foundation models, such as Kestrel, trained on pathology slide images to uncover novel clinical and morphological insights that correlate strongly with patient outcomes. Ataraxis operates in multiple international markets, collaborating with renowned cancer centers and health systems globally to enhance cancer care through its solutions.ai generates revenue primarily through partnerships and collaborations with healthcare institutions and cancer centers, focusing on the provision of its proprietary diagnostic tests. The company operates on a B2B model, entering into agreements with hospitals and clinics that utilize Ataraxis Breast and related services in their treatment protocols. Revenue is structured around diagnostic test fees, where institutions pay for each test conducted on their patient populations.
Who invested in Ataraxis AI
7 investors across 2 rounds
See all investors in Ataraxis AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ataraxis AI
Who invested in Ataraxis AI?
Ataraxis AI has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ataraxis AI raised?
Ataraxis AI has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ataraxis AI last raise money?
Ataraxis AI's most recent round on record is a Series A, in Dec 2024.
What does Ataraxis AI do?
Founded in 2023 and based in New York, US, Ataraxis AI, Inc.
Where is Ataraxis AI headquartered?
Ataraxis AI is headquartered in New York, US.
Which VCs invest in companies like Ataraxis AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Ataraxis AI's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Ataraxis AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.